Clinical Study of Apatinib Mesylate in the Treatment of Platinum Resistant Recurrent Ovarian Cancer

Condition:   Ovarian Cancer Intervention:   Drug: Apatinib mesylate Sponsor:   First Affiliated Hospital of Harbin Medical University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials